It depends on many factors.If the partnership occurs you see .03 to .05 cents.Get the settlement before or after I see at least a dime.
If either of the ongoing trials meet there end points it changes everything.I'm betting SHPG,PFE is already getting feedback regarding both trials.
If that occurs and a buyout occurs its .24 to .60 cents.
I think as one has stated today do it early with bapineuzumab, ponezumab regarding Alzheimer's.Pfizer broke down the data at the end of 2012 regarding bapineuzmab.I feel they know which groups now two treat early for positive outcome.
All that money them top tier companies spent was not wasted.Its was a education.Whomever gets there first has got a lock on a trillion dollar market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.